• Profile
Close

Addition of oral iron bisglycinate to intravenous iron sucrose for the treatment of postpartum anemia - Randomized controlled trial

American Journal of Obstetrics and Gynecology Jun 25, 2021

Yefet E, Rabah SM, Sela ND, et al. - Via performing a randomized controlled trial, researchers aimed at comparing the efficacy of intravenous iron sucrose alone vs intravenous iron sucrose in combination with oral iron bisglycinate supplementation in treating moderate to severe postpartum anemia. Of 158 participants, 63 women receiving intravenous and oral iron and 44 women receiving intravenous iron only, completed the study and were incorporated in the analysis. Outcomes support intravenous 500 mg iron sucrose treatment alone as sufficient to manage postpartum anemia with no necessity of adding oral iron treatment.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay